List of Tables
Table 1. Cholera Vaccines Market Trends
Table 2. Cholera Vaccines Market Drivers & Opportunity
Table 3. Cholera Vaccines Market Challenges
Table 4. Cholera Vaccines Market Restraints
Table 5. Global Cholera Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cholera Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cholera Vaccines Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cholera Vaccines Product Type
Table 9. Key Companies Time to Begin Mass Production of Cholera Vaccines
Table 10. Global Cholera Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cholera Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cholera Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cholera Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cholera Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cholera Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cholera Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cholera Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cholera Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cholera Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cholera Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cholera Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cholera Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cholera Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cholera Vaccines Sales Value by Region (2019-2024) & (%)
Table 27. Global Cholera Vaccines Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cholera Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cholera Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cholera Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 31. Shantha Biotechnics Private Limited Basic Information List
Table 32. Shantha Biotechnics Private Limited Description and Business Overview
Table 33. Shantha Biotechnics Private Limited Cholera Vaccines Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cholera Vaccines Business of Shantha Biotechnics Private Limited (2019-2024)
Table 35. Shantha Biotechnics Private Limited Recent Developments
Table 36. PaxVax, Inc. Basic Information List
Table 37. PaxVax, Inc. Description and Business Overview
Table 38. PaxVax, Inc. Cholera Vaccines Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cholera Vaccines Business of PaxVax, Inc. (2019-2024)
Table 40. PaxVax, Inc. Recent Developments
Table 41. Valneva SE Basic Information List
Table 42. Valneva SE Description and Business Overview
Table 43. Valneva SE Cholera Vaccines Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cholera Vaccines Business of Valneva SE (2019-2024)
Table 45. Valneva SE Recent Developments
Table 46. Merck and Co., Inc. Basic Information List
Table 47. Merck and Co., Inc. Description and Business Overview
Table 48. Merck and Co., Inc. Cholera Vaccines Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cholera Vaccines Business of Merck and Co., Inc. (2019-2024)
Table 50. Merck and Co., Inc. Recent Developments
Table 51. GlaxoSmithKline plc (GSK) Basic Information List
Table 52. GlaxoSmithKline plc (GSK) Description and Business Overview
Table 53. GlaxoSmithKline plc (GSK) Cholera Vaccines Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cholera Vaccines Business of GlaxoSmithKline plc (GSK) (2019-2024)
Table 55. GlaxoSmithKline plc (GSK) Recent Developments
Table 56. Astellas Pharma, Inc. Basic Information List
Table 57. Astellas Pharma, Inc. Description and Business Overview
Table 58. Astellas Pharma, Inc. Cholera Vaccines Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cholera Vaccines Business of Astellas Pharma, Inc. (2019-2024)
Table 60. Astellas Pharma, Inc. Recent Developments
Table 61. Pfizer, Inc. Basic Information List
Table 62. Pfizer, Inc. Description and Business Overview
Table 63. Pfizer, Inc. Cholera Vaccines Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cholera Vaccines Business of Pfizer, Inc. (2019-2024)
Table 65. Pfizer, Inc. Recent Developments
Table 66. Emergent BioSolutions, Inc. Basic Information List
Table 67. Emergent BioSolutions, Inc. Description and Business Overview
Table 68. Emergent BioSolutions, Inc. Cholera Vaccines Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cholera Vaccines Business of Emergent BioSolutions, Inc. (2019-2024)
Table 70. Emergent BioSolutions, Inc. Recent Developments
Table 71. Mitsubishi Tanabe Pharma Corporation Basic Information List
Table 72. Mitsubishi Tanabe Pharma Corporation Description and Business Overview
Table 73. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cholera Vaccines Business of Mitsubishi Tanabe Pharma Corporation (2019-2024)
Table 75. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 76. Takeda Pharmaceutical Co., Ltd. Basic Information List
Table 77. Takeda Pharmaceutical Co., Ltd. Description and Business Overview
Table 78. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cholera Vaccines Business of Takeda Pharmaceutical Co., Ltd. (2019-2024)
Table 80. Takeda Pharmaceutical Co., Ltd. Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Cholera Vaccines Downstream Customers
Table 84. Cholera Vaccines Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cholera Vaccines Product Picture
Figure 2. Global Cholera Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cholera Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Cholera Vaccines Report Years Considered
Figure 5. Global Cholera Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cholera Vaccines Revenue in 2023
Figure 7. Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Dukoral Picture
Figure 9. Shanchol Picture
Figure 10. Vaxchora Picture
Figure 11. Others Picture
Figure 12. Global Cholera Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Cholera Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Oral
Figure 15. Product Picture of Others
Figure 16. Global Cholera Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Cholera Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Cholera Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Cholera Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Cholera Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Cholera Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Cholera Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Cholera Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Cholera Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Cholera Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Cholera Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Cholera Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Cholera Vaccines Sales Value (%), (2019-2030)
Figure 29. United States Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Cholera Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Cholera Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Cholera Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Cholera Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 35. China Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Cholera Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 37. China Cholera Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Cholera Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Cholera Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Cholera Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Cholera Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Cholera Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Cholera Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 47. India Cholera Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Cholera Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 49. India Cholera Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 50. Cholera Vaccines Industrial Chain
Figure 51. Cholera Vaccines Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
